Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Non-Current Liabilities: 2023

  • Upstream Bio's Total Non-Current Liabilities was N/A to $6.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $6.5 million, marking a year-over-year change of. This contributed to the annual value of $6.5 million for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2023, Upstream Bio's Total Non-Current Liabilities is $6.5 million.
  • Upstream Bio's Total Non-Current Liabilities' 5-year high stood at $6.5 million during Q4 2023, with a 5-year trough of $6.5 million in Q4 2023.
  • Over the past 1 years, Upstream Bio's median Total Non-Current Liabilities value was $6.5 million (recorded in 2023), while the average stood at $6.5 million.